The University grant Commission, New Delhi has sent a communication to all Universities regarding the recent decision of the Government to regulate the prices of coronary stents is a very important milestone in regulation of prices of drugs and medical devices, which is aimed to substantially reduce the burden on the pockets of the poor patients and their kin.
There is a very high incident of Coronary Artery Disease (CAD) in India associated with high morbidity and mortality and coronary stent implantation is an important treatement. The Central Government has, therefore, included the same in the schedule 1 of the Drugs (Price control) order, 2013 on 21.12.2016 enabling National Pharmaceuticals Pricing Authority (NPPA) to regulate the prices of coronary stents and monitor their availability.
NPPA, after detailed stakeholder consultations, notified the ceiling prices of the coronary stents on 13.02.2017 under categories:
|1||Bare Metal Stents||Rs. 7,260/-|
|2||Drug Eluting metallic DES and including Stents (DES) and Bio-resorbable Vascular Scaffold (BVs) / Biodegradable Stents||Rs. 29,600/-|